OCUL · Company research
Ocular Therapeutix, Inc. (OCUL): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
18records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Ocular Therapeutix (OCUL) Stock May Be Fully Priced Given Its Sales Base - Simply Wall Street | Ocular Therapeutix (OCUL) Stock May Be Fully Priced Given Its Sales Base Simply Wall Street | View source ↗ | Simply Wall Street | Oct 18, 2026 | neutral | 0 | 0.6 |
| OCUL Stock Suffers Sharpest Drop Since February As KOD And FDMT Post Updates On Their Wet AMD Drugs - Stocktwits | OCUL Stock Suffers Sharpest Drop Since February As KOD And FDMT Post Updates On Their Wet AMD Drugs Stocktwits | View source ↗ | Stocktwits | Oct 16, 2026 | neutral | 0 | 0.6 |
| (OCUL) Risk Channels and Responsive Allocation - Stock Traders Daily | (OCUL) Risk Channels and Responsive Allocation Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 16, 2026 | neutral | 0 | 0.6 |
| Ocular Therapeutix, Inc. (OCUL) Presents at American Academy of Ophthalmology Retina Subspeciality Day - Slideshow (NASDAQ:OCUL) 2026-10-15 - Seeking Alpha | Ocular Therapeutix, Inc. (OCUL) Presents at American Academy of Ophthalmology Retina Subspeciality Day - Slideshow (NASDAQ:OCUL) 2026-10-15 Seeking Alpha | View source ↗ | Seeking Alpha | Oct 15, 2026 | neutral | 0 | 0.6 |
| To cover vesting taxes, Ocular Therapeutix (OCUL) legal chief sold 11,984 shares. - Stock Titan | To cover vesting taxes, Ocular Therapeutix (OCUL) legal chief sold 11,984 shares. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| OCUL Stock In Spotlight After Q2 Loss Comes In Narrower Than Estimated – A Look At Key Highlights - Stocktwits | OCUL Stock In Spotlight After Q2 Loss Comes In Narrower Than Estimated – A Look At Key Highlights Stocktwits | View source ↗ | Stocktwits | Oct 12, 2026 | neutral | 0 | 0.6 |
| OCUL, FDMT Stock Clock Best Day In Weeks After EyePoint’s Trial Setback — Here’s Why - Stocktwits | OCUL, FDMT Stock Clock Best Day In Weeks After EyePoint’s Trial Setback — Here’s Why Stocktwits | View source ↗ | Stocktwits | Oct 12, 2026 | neutral | 0 | 0.6 |
| OCUL Stock Is Climbing Ahead Of Investor Day — What Is On The Agenda? - Stocktwits | OCUL Stock Is Climbing Ahead Of Investor Day — What Is On The Agenda? Stocktwits | View source ↗ | Stocktwits | Oct 11, 2026 | neutral | 0 | 0.6 |
| 15 new hires receive stock awards from Ocular Therapeutix - Stock Titan | 15 new hires receive stock awards from Ocular Therapeutix Stock Titan | View source ↗ | Stock Titan | Oct 9, 2026 | neutral | 0 | 0.6 |
| Officer Todd Anderman proposes selling 11,984 shares of Ocular Therapeutix (OCUL). - Stock Titan | Officer Todd Anderman proposes selling 11,984 shares of Ocular Therapeutix (OCUL). Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| Ocular Therapeutix (NasdaqGM:OCUL) Stock Forecast & Analyst Predictions - Simply Wall Street | Ocular Therapeutix (NasdaqGM:OCUL) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 2, 2026 | neutral | 0 | 0.6 |
| Ocular Therapeutix (OCUL) Stock Still Looks Pricey As 145% Gain Draws Scrutiny - Yahoo Finance | Ocular Therapeutix (OCUL) Stock Still Looks Pricey As 145% Gain Draws Scrutiny Yahoo Finance | View source ↗ | Yahoo Finance | Oct 2, 2026 | neutral | 0 | 0.6 |
| A Phase 3 eye-treatment trial is set for an October results presentation - Stock Titan | A Phase 3 eye-treatment trial is set for an October results presentation Stock Titan | View source ↗ | Stock Titan | Oct 1, 2026 | neutral | 0 | 0.6 |
| $OCUL stock is down 23% today. Here's what we see in our data. - Quiver Quantitative | $OCUL stock is down 23% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 28, 2026 | neutral | 0 | 0.6 |
| $OCUL stock is down 23% today. Here's what we see in our data. - Quiver Quantitative | $OCUL stock is down 23% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 28, 2026 | neutral | 0 | 0.6 |
| Is Ocular Therapeutix (OCUL) Stock a Buy Ahead of Its Major NDA Catalyst? - Yahoo Finance | Is Ocular Therapeutix (OCUL) Stock a Buy Ahead of Its Major NDA Catalyst? Yahoo Finance | View source ↗ | Yahoo Finance | Sep 23, 2026 | neutral | 0 | 0.6 |
| Ocular Therapeutix (OCUL) Stock Fair Value Edges Higher After Analyst Target Increases - Yahoo Finance | Ocular Therapeutix (OCUL) Stock Fair Value Edges Higher After Analyst Target Increases Yahoo Finance | View source ↗ | Yahoo Finance | Aug 21, 2026 | neutral | 0 | 0.6 |
| Ocular Therapeutix (OCUL) Stock Faces Axpaxli Hopes Against Deepening Losses - Simply Wall Street | Ocular Therapeutix (OCUL) Stock Faces Axpaxli Hopes Against Deepening Losses Simply Wall Street | View source ↗ | Simply Wall Street | Aug 4, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.